Ads
related to: doctors expect one flu strain
Search results
Despite its 'nothingburger' reputation, COVID-19 remains deadlier than the flu
LA Times via Yahoo News· 6 days ago“Even when COVID becomes equal to the flu, it’s still sobering and significant." The researchers...
New virus variants threaten a summer Covid-19 wave, but experts say the risk remains uncertain
CNN via Yahoo News· 4 days agoCovid-19 levels are about the lowest they’ve ever been in the United States, but another new crop of...
Latest COVID worry, FLiRT variants, sparks concern about vaccination rates
Los Angeles Daily News· 3 days agoA new family of COVID variants nicknamed “FLiRT” is spreading across the country, as vaccination...
Opinion: How to prepare for our latest viral threat | CNN
CNN.com· 5 hours agoFrank Luntz is a Republican pollster and communication adviser. Once again, our nation is monitoring...
Scientists Await Updates on H5N1 Situation in Canada
Medscape· 6 days agoAs the H5N1 avian influenza virus continues to spread among poultry and cattle in the United States — and has infected a dairy worker in Texas — public...
No bird flu cases found yet in North Dakota cows, but industry, state officials watchful
The Bismarck Tribune· 4 days agoReports of bird flu spilling into dairy cattle herds across the United States have raised concerns...
CDC monitoring cases of bird flu across the U.S.
NBC San Diego· 5 days agoThe medical science community is on alert after recent reports of bird flu outbreaks across the U.S. According to the Centers for Disease Control and...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoSAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoCompleted acquisition of Trawsfynydd and concurrent $14 million Capital Raise Excellent pipeline progress, led by candidates for COVID 19, influenza, and oncology programs Poised to initiate Phase 2 studies in H2 2024 for our influenza candidate